Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-21
2006-02-21
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S350000, C530S395000, C530S378000, C435S069700, C435S440000
Reexamination Certificate
active
07001882
ABSTRACT:
The present invention relates to muteins of the bilin-binding protein with binding activity to digoxigenin and to fusion proteins of such muteins, a method for preparing said muteins and fusion proteins thereof and their utilization for detecting or binding digoxigenin-labeled biomolecules. The invention especially relates to a polypeptide selected from muteins of the bilin-binding protein, characterized in that (a) it can bind digoxigenin or digoxigenin conjugates, (b) it does not bind ouabain, testosterone, and 4-aminofluorescein and (c) at least one of the sequence positions 28, 31, 34, 35, 36, 37, 58, 60, 69, 88, 90, 95, 97, 114, 116, 125, and 127 of the bilin-binding protein has an amino acid substitution. Due to their simple molecular structure, the inventive muteins provide advantages for production and utilization in comparison with antibodies against the digoxigenin group.
REFERENCES:
patent: 0 835 934 (1998-04-01), None
patent: 89/06698 (1989-07-01), None
patent: 99/16873 (1999-04-01), None
Beste et al., “Small Antibody-Like Proteins with Prescribed Ligand Specificities Derived From the Lipocalin Fold,” Biochemistry, Proceeding of the National Academy of Science of the United States, vol. 96, No. 5, pp. 1898-1903, Mar. 2, 1999.
Flower, “The Lipocalin Protein Family: Structure and Function,” Biochemical Journal, vol. 318, pp. 1-14, 1996.
Schmidt et al, “The Bilin-Binding Protein ofPieris brassicaecDNA Sequence and Regulation of Expression Reveal Distinct Features of this Insect Pigment Protein,” European Journal of Biochemistry, vol. 219, No. 3, FEBS, pp. 855-863, 1994.
Schlehuber et al., “A Novel Type of Receptor Protein, Based on the Lipocalin Scaffold, with Specificity for Digoxigenin,” Journal of Molecular Biology, vol. 297, No. 5, Academic Press, pp. 1105-1120, Apr. 14, 2000.
Carlson Karen Cochrane
Liu Samuel Wei
Pieris Proteolab AG
LandOfFree
Muteins of bilin-binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muteins of bilin-binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muteins of bilin-binding protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3683279